Les Laboratoires Servier SAS:企業の戦略的SWOT分析

◆英語タイトル:Les Laboratoires Servier SAS - Strategic SWOT Analysis Review
◆商品コード:GDPH30956SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Les Laboratoires Servier SAS – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company’s portfolio of marketed products treats central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, hematological disorders, hormonal disorders and others. It invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. It sells products in Europe, America, Middle East, Africa and Asia. Servier headquartered in Suresnes, France.

Les Laboratoires Servier SAS Key Recent Developments

Dec 22,2020: Servier to acquire oncology business from Agios Pharmaceuticals for $2bn
Dec 14,2020: The French Bioproduction Sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
Dec 14,2020: The Servier Group opens a worldwide Artificial Intelligence hub in Montreal, in partnership with Centech
Dec 11,2020: Servier partners with Digestive Cancers Europe to co-create brochures with and for patients
Dec 10,2020: Streaming of the Pasteur-Weizmann Scientific Conference

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Les Laboratoires Servier SAS – Key Facts
Les Laboratoires Servier SAS – Key Employees
Les Laboratoires Servier SAS – Key Employee Biographies
Les Laboratoires Servier SAS – Major Products and Services
Les Laboratoires Servier SAS – History
Les Laboratoires Servier SAS – Company Statement
Les Laboratoires Servier SAS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Les Laboratoires Servier SAS – Business Description
Product Category: Branded Medicines
Performance
Product Category: Generic Medicines
Performance
Geographical Segment: Africa and Middle East
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia and Oceania
Performance
Geographical Segment: Europe (Outside the EU)
Performance
Geographical Segment: European Union
Performance
Les Laboratoires Servier SAS – SWOT Analysis
SWOT Analysis – Overview
Les Laboratoires Servier SAS – Strengths
Les Laboratoires Servier SAS – Weaknesses
Les Laboratoires Servier SAS – Opportunities
Les Laboratoires Servier SAS – Threats
Les Laboratoires Servier SAS – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Les Laboratoires Servier SAS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 14, 2020: The French Bioproduction Sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
Dec 14, 2020: The Servier Group opens a worldwide Artificial Intelligence hub in Montreal, in partnership with Centech
Dec 11, 2020: Servier partners with Digestive Cancers Europe to co-create brochures with and for patients
Dec 10, 2020: Streaming of the Pasteur-Weizmann Scientific Conference
Dec 08, 2020: Servier launches its first oncology treatment in the Solid Tumor Field in Brazil
Nov 27, 2020: Servier launches My Health Partner, an innovative platform for patients
Nov 27, 2020: Servier China and Alibaba Health joins hands for the benefit of patients
Nov 19, 2020: Skolkovo and Servier support Russian startups in the field of oncology and autoimmune diseases
Nov 11, 2020: Towards an even more diverse and inclusive Servier: servierdiversity, a CSR Program
Oct 17, 2020: World Hypertension Day: Servier committed in the fight against HTA
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS, Key Employees
Les Laboratoires Servier SAS, Key Employee Biographies
Les Laboratoires Servier SAS, Major Products and Services
Les Laboratoires Servier SAS, History
Les Laboratoires Servier SAS, Subsidiaries
Les Laboratoires Servier SAS, Key Competitors
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Les Laboratoires Servier SAS, Recent Deals Summary

★海外企業調査レポート[Les Laboratoires Servier SAS:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析
    Summary Alfred E. Tiefenbacher (GmbH & Co KG) (AET) is a healthcare products provider that develops active pharmaceuticals ingredients. The company’s products comprise cytotoxic drugs, hormones, OTC drugs, controlled drugs, herbal drugs, high potent drugs, new combination products, inhaler technolog …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務分析
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bovie Medical Corp (BVX)-医療機器分野:企業M&A・提携分析
    Summary Bovie Medical Corp (Bovie Medical) is a manufacturer of medical devices and supplies. The company offers J-plasma, electrosurgery, veterinary products, acudop ii dopplers, clearspec speculum, colposcopes, cryosurgery, dermascout dermatoscope, medical lights, nerve locators, ophthalmic produc …
  • MolMed SpA (MLM):製薬・医療:M&Aディール及び事業提携情報
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Premier Oil Plc (PMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Premier Oil Plc (Premier Oil) is an independent upstream oil and gas company. It explores for, develops and produces crude oil and natural gas. The company has interests in the North Sea, South East Asia, Pakistan, the Falkland Islands and Latin America. It explores under-explored proven hyd …
  • AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, infl …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • OpenHydro Group Limited:電力:M&Aディール及び事業提携情報
    Summary OpenHydro Group Limited (OpenHydro) a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. It …
  • China Southern Airlines Company Limited:戦略・SWOT・企業財務分析
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary BioLife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • Cogent Communications Holdings inc (CCOI):企業の財務・戦略的SWOT分析
    Cogent Communications Holdings inc (CCOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Himatsingka Seide Ltd:企業の戦略・SWOT・財務分析
    Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report Summary Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • National Bank of Egypt S.A.E:企業の戦略・SWOT・財務分析
    National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report Summary National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Suntory Holdings Ltd:企業の戦略・SWOT・財務情報
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Contango Oil & Gas Co (MCF):石油・ガス:M&Aディール及び事業提携情報
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …
  • Roper Technologies Inc (ROP):医療機器:M&Aディール及び事業提携情報
    Summary Roper Technologies Inc (Roper), formerly Roper Industries Inc, is a diversified technology company. It designs and develops software, and engineered products and solutions. It offers both software-as-a-service and licensed to customers. The company serves healthcare, water, food, transportat …
  • Cellectis SA (ALCLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆